Bridgefront Capital, LLC Amneal Pharmaceuticals, Inc. Transaction History
Bridgefront Capital, LLC
- $249 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
184Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$171 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$115 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$96.8 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$88.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$84.2 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.19B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...